Physician profile
Patrick Timothy Clark
NPI 1972609436
$4,756.45
in general payments reported to CMS, 2019-2025
39 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 84% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $902 · 2022: $620 · 2023: $1,285 · 2024: $708 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,234.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $991.03 | 2021-2025 | Breztri, Farxiga, Fasenra |
| Novo Nordisk INC | $391.81 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $369.58 | 2021-2024 | |
| Amgen INC. | $284.09 | 2021-2025 | Repatha, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $226.10 | 2022-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $181.12 | 2021-2025 | Nexletol |
| Axsome Therapeutics, INC. | $161.76 | 2025 | Auvelity |
| Radius Health, INC. | $149.15 | 2023 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $143.23 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $137.45 | 2025 | Amvuttra, Onpattro |
| Pfizer INC. | $136.61 | 2022-2025 | |
| Lilly USA, LLC | $127.04 | 2021-2024 | Mounjaro, Trulicity |
| Actelion Pharmaceuticals US, INC. | $126.75 | 2024 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $105.97 | 2021-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Intuitive Surgical, INC. | $103.24 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $100.14 | 2023-2025 | Korlym |
| Exact Sciences Corporation | $97.04 | 2023-2024 | Cologuard Collection Kit |
| Scilex Pharmaceuticals INC. | $81.90 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $76.77 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $74.63 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $67.05 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Abbott Laboratories | $66.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $57.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.54 | 2021-2022 | |
| Amarin Pharma, INC. | $47.55 | 2021 | |
| Dexcom, INC. | $45.09 | 2023-2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $44.96 | 2021-2022 | |
| Dentsply Sirona INC | $41.81 | 2021 | |
| Idorsia Pharmaceuticals US INC | $40.95 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $37.11 | 2021-2023 | Trelegy Ellipta |
| Philips North America LLC | $34.54 | 2025 | Extended Holter |
| Otsuka America Pharmaceutical, INC. | $29.06 | 2023 | Rexulti |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.04 | 2025 | Lifevest |
| Vanda Pharmaceuticals INC. | $24.10 | 2023 | Hetlioz |
| Inspire Medical Systems, INC. | $21.45 | 2024 | Inspire |
| Cashflow Solutions, LLC | $15.41 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bausch Health US, LLC | $14.18 | 2021 | |
| Eisai INC. | $13.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.